Abingdon Health (ABDX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 10.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 15.00
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 121.72m
  • Volume: 224,755
  • Market Cap: £12.78m

Abingdon Health rolling out saliva-based pregnancy test

By Josh White

Date: Monday 19 Jun 2023

LONDON (ShareCast) - (Sharecast News) - Abingdon Health announced the release of 'Salistick', a saliva pregnancy test, in the United Kingdom and Ireland on Monday.
The AIM-traded firm said the product would provide women with an enhanced user experience, delivering high accuracy for early pregnancy detection, using patented saliva technology instead of traditional urine tests.

It said Salistick allows for convenient testing anywhere and at any time, fostering the opportunity to share the testing experience with partners and loved ones.

Salignostics, an Israel-based developer of saliva-based diagnostic tests, had entrusted Abingdon as the exclusive distributor of Salistick in the UK and Ireland.

Abingdon had provided distribution support, and offered contract development services to Salignostics, aiding in the scaling-up of the Salistick product for manufacturing.

The company said it would continue to provide contract manufacturing services to Salignostics in the future.

Abingdon added that it was partnering with retailer Superdrug for the launch of Salistick.

Initially, the product would be rolled out across 400 Superdrug stores, and will be available for purchase on Superdrug.com.

Additionally, Abingdon would introduce Salistick through its direct-to-consumer e-commerce channel, 'Abingdon Simply Test'.

The product would be co-branded as 'Abingdon Simply Test', expanding the range of self-tests available under the brand line to more than 15.

Abingdon said it was aiming to continuously broaden its selection of self-tests by partnering with companies like Salignostics in a bid to provide consumers with the best novel self-test technologies available in the market.

"We are delighted to announce the launch of Salistick, initially across 400 Superdrug stores and at Superdrug.com," said chief executive officer Chris Yates.

"This novel technology provides women with an enhanced user-experience; offering the ability to test anywhere, anytime, and for the experience to be shared with a partner and other loved ones.

"We are pleased to have supported our partner Salignostics through the development process into manufacturing and now commercial launch, and we look forward to deepening our collaboration as we move forward."

At 1058 BST, shares in Abingdon Health were up 8.88% at 16p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ABDX Market Data

Currency UK Pounds
Share Price 10.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 15.00
52 Week Low 6.75
Volume 224,755
Shares Issued 121.72m
Market Cap £12.78m

ABDX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.93% below the market average42.93% below the market average42.93% below the market average42.93% below the market average42.93% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average
Price Trend
47.13% above the market average47.13% above the market average47.13% above the market average47.13% above the market average47.13% above the market average
45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average45.95% above the sector average
Income Not Available
Growth
3.76% above the market average3.76% above the market average3.76% above the market average3.76% above the market average3.76% above the market average
5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average

ABDX Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
16:04 6,690 @ 10.00p
14:31 2,302 @ 10.34p
13:32 4,778 @ 10.34p
13:30 5,203 @ 10.34p
12:33 25,000 @ 10.00p

ABDX Key Personnel

CEO Chris Henry Francis Yates

Top of Page